Design, synthesis and biological evaluation of novel HIV-1 protease inhibitors with pentacyclic triterpenoids as P2-ligands.
Bioorg Med Chem Lett
; 29(3): 357-361, 2019 02 01.
Article
en En
| MEDLINE
| ID: mdl-30580917
ABSTRACT
The design, synthesis and SAR study of a new series of HIV-1 protease inhibitors with pentacyclic triterpenoids as P2 ligands and phenylsulfonamide as P2' ligands were discussed. These compounds exhibited micromolar inhibitory potency, among which compound T1c displayed HIV-1 protease inhibition with IC50 values of 0.12⯵M, which was 67 times the inhibitory activity of its raw material Ursolic acid (8.0⯵M).
Palabras clave
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Sulfonamidas
/
Diseño de Fármacos
/
Proteasa del VIH
/
Inhibidores de la Proteasa del VIH
/
Fármacos Anti-VIH
/
Triterpenos Pentacíclicos
Límite:
Humans
Idioma:
En
Revista:
Bioorg Med Chem Lett
Asunto de la revista:
BIOQUIMICA
/
QUIMICA
Año:
2019
Tipo del documento:
Article
País de afiliación:
China